← Back to Search

Insulin

Aspart insulin for Type 1 Diabetes

Q: Who qualifies for inclusion in this clinical research?

For this study, enrolment is limited to 12 minors who have <a href="https://www.withpower.com/clinical-trials/type-1-diabetes">type 1 diabetes</a> mellitus, aged between 9 and 15 years old. Additionally, participants must demonstrate the capacity for informed consent in order to be eligible.

Q: What precedent has there been for research involving Aspart insulin?

Presently, 78 trials are underway to evaluate the efficacy of Aspart insulin. Of those studies, 14 have advanced to Phase 3 testing. Though most research is happening in Sao Luis, MA, there are 377 clinical trial sites across multiple nations involved in this investigation.

Q: In what scenarios does Aspart insulin commonly come into play?

Aspart insulin is a versatile drug that can treat multiple conditions, including <a href="https://www.withpower.com/clinical-trials/diabetes">diabetes</a> mellitus type 1, ketoacidosis due to diabetes mellitus and critical illnesses.

Q: Is this research accommodating elderly applicants?

This clinical trial is enrolling individuals aged 9 to 15 years old.

Q: What is the maximum capacity for participating in this clinical trial?

Affirmative. Clinicaltrials.gov indicates that recruitment for this study is ongoing, having been first posted on January 1st 2020 and last revised on May 19th 2022. 12 individuals are needed to be enrolled from one single medical centre.

Q: Is there any remaining capacity to participate in this investigation?

Yes, indeed. As per the information on clinicaltrials.gov, this research is still seeking out suitable candidates. The original posting was in January 2020 and it has been updated as recently as May 2022. Presently, 12 participants are needed from 1 medical centre for enrolment into the trial.

Phase < 1

Waitlist Available

Led By Jennifer Sherr, MD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 240 minutes

Awards & highlights

Study Summary

This trial will compare the PK of diluted insulin aspart to undiluted insulin aspart in children and adolescents with T1D.

Eligible Conditions

Type 1 Diabetes

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 240 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~240 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 240 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

maximum insulin concentration

Secondary outcome measures

GIR Max

Mean Glucose Infusion Rate (GIR)

Time to GIR Max

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Aspart-U25 InsulinExperimental Treatment1 Intervention

Diluted Concentration of Rapid Acting Insulin

Group II: Aspart-U100 InsulinActive Control1 Intervention

Standard Concentration Rapid Acting Insulin

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Aspart insulin

2017

Completed Phase 4

~120

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Juvenile Diabetes Research FoundationOTHER

232 Previous Clinical Trials

141,781 Total Patients Enrolled

Yale UniversityLead Sponsor

1,848 Previous Clinical Trials

2,737,815 Total Patients Enrolled

Jennifer Sherr, MDPrincipal InvestigatorYale University

1 Previous Clinical Trials

186 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who qualifies for inclusion in this clinical research?

"For this study, enrolment is limited to 12 minors who have type 1 diabetes mellitus, aged between 9 and 15 years old. Additionally, participants must demonstrate the capacity for informed consent in order to be eligible."

Answered by AI

What precedent has there been for research involving Aspart insulin?

"Presently, 78 trials are underway to evaluate the efficacy of Aspart insulin. Of those studies, 14 have advanced to Phase 3 testing. Though most research is happening in Sao Luis, MA, there are 377 clinical trial sites across multiple nations involved in this investigation."

Answered by AI

In what scenarios does Aspart insulin commonly come into play?

"Aspart insulin is a versatile drug that can treat multiple conditions, including diabetes mellitus type 1, ketoacidosis due to diabetes mellitus and critical illnesses."

Answered by AI

Is this research accommodating elderly applicants?

"This clinical trial is enrolling individuals aged 9 to 15 years old."

Answered by AI

What is the maximum capacity for participating in this clinical trial?

"Affirmative. Clinicaltrials.gov indicates that recruitment for this study is ongoing, having been first posted on January 1st 2020 and last revised on May 19th 2022. 12 individuals are needed to be enrolled from one single medical centre."

Answered by AI

Is there any remaining capacity to participate in this investigation?

"Yes, indeed. As per the information on clinicaltrials.gov, this research is still seeking out suitable candidates. The original posting was in January 2020 and it has been updated as recently as May 2022. Presently, 12 participants are needed from 1 medical centre for enrolment into the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients

2020. "Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03666065.